These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 25368269)

  • 21. Outcomes and Characteristics of Patients Treated with Emergent Palliative Radiation Therapy.
    Grade M; Koenig J; Qian Y; Sandhu N; Liu Y; Turner B; von Eyben R; Knox S; Dudley S
    Pract Radiat Oncol; 2019 Mar; 9(2):e203-e209. PubMed ID: 30529795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors in 1,521 melanoma patients with distant metastases.
    Barth A; Wanek LA; Morton DL
    J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short survival after palliative radiotherapy for brain metastases in lung cancer: does the end justify the means?
    Ampil FL; Caldito G; Mills G; Marion J; Balandin A; Ponugupati J
    Am J Hosp Palliat Care; 2013 Jun; 30(4):331-3. PubMed ID: 22743230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating the need for palliative radiotherapy for brain metastasis: a benchmarking approach.
    Kong W; Jarvis C; Mackillop WJ
    Clin Oncol (R Coll Radiol); 2015 Feb; 27(2):83-91. PubMed ID: 25481789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole brain radiotherapy: prognostic factors and results of a radiation boost delivered through a conventional linear accelerator.
    Assouline A; Levy A; Chargari C; Lamproglou I; Mazeron JJ; Krzisch C
    Radiother Oncol; 2011 May; 99(2):214-7. PubMed ID: 21620502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
    Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
    Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
    Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How Should Palliative Thoracic Radiotherapy Be Fractionated for Octogenarians with Lung Cancer?
    Nieder C; Yobuta R; Mannsåker B; Dalhaug A
    In Vivo; 2018; 32(2):331-336. PubMed ID: 29475917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An analysis of the survival rate after radiotherapy in lung cancer patients with bone metastasis: is there an optimal subgroup to be treated with high-dose radiation therapy?
    Komatsu T; Kunieda E; Oizumi Y; Tamai Y; Akiba T
    Neoplasma; 2012; 59(6):650-7. PubMed ID: 22862159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions.
    Inoue T; Katoh N; Aoyama H; Onimaru R; Taguchi H; Onodera S; Yamaguchi S; Shirato H
    Jpn J Clin Oncol; 2010 Aug; 40(8):788-94. PubMed ID: 20406944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
    Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
    Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival differences in patients with metastatic colorectal cancer and with single site metastatic disease at initial presentation: results from South Australian clinical registry for advanced colorectal cancer.
    Khattak MA; Martin HL; Beeke C; Price T; Carruthers S; Kim S; Padbury R; Karapetis CS
    Clin Colorectal Cancer; 2012 Dec; 11(4):247-54. PubMed ID: 22763194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life and symptoms control in brain metastasis after palliative whole brain radiotherapy using two different protocols.
    Akhtar MS; Kousar F; Fatmi S; Jabeen K; Akhtar K
    J Coll Physicians Surg Pak; 2012 May; 22(5):311-6. PubMed ID: 22538037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of a surgical resection for patients with stage IV non--small-cell lung cancer.
    Hanagiri T; Takenaka M; Oka S; Shigematsu Y; Nagata Y; Shimokawa H; Uramoto H; Tanaka F
    Clin Lung Cancer; 2012 May; 13(3):220-4. PubMed ID: 22138036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
    Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
    J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of curative and palliative radiotherapy efficacy in unresectable advanced non-small cell lung cancer patients with or without metastasis.
    Unlu I; Diniz G; Komurcuoglu B; Gayaf M; Gokce T; Karadogan I; Akcay C
    Saudi Med J; 2006 Jun; 27(6):849-53. PubMed ID: 16758049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective analysis of survival outcomes for two different radiotherapy fractionation schedules given in the same overall time for limited stage small cell lung cancer.
    Bettington CS; Tripcony L; Bryant G; Hickey B; Pratt G; Fay M
    J Med Imaging Radiat Oncol; 2013 Feb; 57(1):105-12. PubMed ID: 23374562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distant metastasis in triple-negative breast cancer.
    Tseng LM; Hsu NC; Chen SC; Lu YS; Lin CH; Chang DY; Li H; Lin YC; Chang HK; Chao TC; Ouyang F; Hou MF
    Neoplasma; 2013; 60(3):290-4. PubMed ID: 23373998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.